The European Partnership for Personalised Medicine (EP PerMed) will organize an online Information Day on 16 December 2025 to introduce the Joint Transnational Call 2026 (JTC2026), titled CARMEN2026.

With an available budget of approximately €38 million, JTC2026 aims to fund innovative research projects on Personalised Medicine strategies for patients with cardiovascular, metabolic, or kidney diseases. Projects can focus on a single disease or explore these conditions in combination. Proposals should address aspects such as innovative personalized therapeutic approaches, monitoring of treatment response, or early disease risk prediction and prevention.

The call will be implemented in two stages:

• Pre-Proposal Submission Deadline: 10 February 2026 (16.00)
• Full Proposal Submission Deadline: 09 June 2026 (15.00)

The information day agenda includes a welcome by the EP PerMed Coordinator, an introduction to JTC2026, and a Q&A session.

👉 Further details about the event are available here.

👉 You can register to the event from here.